Evidence map›Paper›PMID 26334841›Full record

ArticleZeitschrift fur Gerontologie und Geriatrie2015

C-reactive protein and the acute phase reaction in geriatric patients.

Thomas Bertsch, Jakob Triebel, Cornelius Bollheimer, Michael Christ, Cornel Sieber, Klaus Fassbender, Hans Jürgen Heppner

Abstract read
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Gerontologie und Geriatrie, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Thomas BertschInstitute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University, General Hospital Nuremberg, Prof. Ernst-Nathan-Str. 1, 90419, Nuremberg, Germany. thomas.bertsch@klinikum-nuernberg.de.
Jakob TriebelInstitute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University, General Hospital Nuremberg, Prof. Ernst-Nathan-Str. 1, 90419, Nuremberg, Germany.
Cornelius BollheimerDepartment of General Internal Medicine and Geriatrics, St. John of God Hospital Regensburg, Regensburg, Germany.
Michael ChristDepartment of Emergency Medicine and Intensive Care, Paracelsus Medical University, General Hospital Nuremberg, Nuremberg, Germany.
Cornel SieberDepartment of General Internal Medicine and Geriatrics, St. John of God Hospital Regensburg, Regensburg, Germany.
Klaus FassbenderDepartment of Neurology, Saarland University Hospital, Homburg, Germany.
Hans Jürgen HeppnerDepartment of Geriatrics, Helios Klinikum Schwelm -Chair of Geriatrics of Witten-Herdecke University, Schwelm, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DENuremberg Hospital · DESaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The C-reactive protein (CRP), first described as a serum component capable of precipitating the C-polysaccharide of pneumococci, is one of the most important proteins because the serum concentration rises in the acute phase reaction. The acute phase reaction is the nonspecific reaction of the body to noxious stimuli of the most varied kinds, such as infections, burns, neoplasms and tissue trauma. The CRP is synthesized in liver parenchymal cells by cytokines which are derived from stimulated leucocytes and released into the circulation. Because of its molecular structure and in synergy with the complement system, it is able to precipitate and/or lyse microorganisms, thereby rendering them harmless. Measurement of the serum CRP concentration can provide important information with respect to the diagnosis and monitoring of treatment. Due to immunosenescence in geriatric patients the synthesis of CRP appears to be limited to inflammatory stimuli; however, this phenomenon does not appear to be of major clinical relevance. Despite the introduction of new parameters of the acute phase reaction, sometimes with better performance, such as interleukin-6, procalcitonin and the soluble endotoxin receptor sCD14, measurement of CRP for diagnosis and treatment monitoring is still justified even in geriatric patients as testing is rapid, economic and nearly ubiquitously available round the clock. Biochemical markers of the acute phase reaction should always be interpreted together with the clinical picture and their specific limitations.

Indexed as

Acute-Phase ReactionAgedAged, 80 and overBiomarkersC-Reactive ProteinCytokinesFemaleGeriatric AssessmentHumansMaleRisk AssessmentBiomarkersC-Reactive ProteinCytokinesAcute phase reactionC-reactive proteinGeriatricsInfectionInnate immune response

Identifiers

PMID26334841
OpenAlexW2134174943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.